Financial results - WORLDWIDE CLINICAL TRIALS LIMITED LONDRA SUCURSALA BUCURESTI

Financial Summary - Worldwide Clinical Trials Limited Londra Sucursala
Unique identification code: 25575730
Registration number: J40/6051/2009
Nace: 7490
Sales - Ron
4.911.836
Net Profit - Ron
346.159
Employees
65
Open Account
Company Worldwide Clinical Trials Limited Londra Sucursala with Fiscal Code 25575730 recorded a turnover of 2024 of 4.911.836, with a net profit of 346.159 and having an average number of employees of 65. The company operates in the field of Alte activitati profesionale, stiintifice si tehnice n.c.a. having the NACE code 7490.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Worldwide Clinical Trials Limited Londra Sucursala

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 830.824 986.153 1.078.901 1.095.485 1.477.288 1.409.977 1.682.349 2.414.588 3.688.808 4.911.836
Total Income - EUR 831.265 986.982 1.079.421 1.095.981 1.477.508 1.450.913 1.686.068 2.420.704 3.689.240 4.924.507
Total Expenses - EUR 799.287 952.516 1.062.897 1.038.726 1.332.608 1.352.050 1.543.440 2.215.218 3.387.566 4.506.276
Gross Profit/Loss - EUR 31.978 34.466 16.524 57.255 144.900 98.863 142.629 205.485 301.674 418.231
Net Profit/Loss - EUR 24.784 26.479 5.197 42.518 117.874 83.638 120.464 172.694 251.889 346.159
Employees 11 14 14 12 13 15 19 30 44 65
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 33.9%, from 3.688.808 euro in the year 2023, to 4.911.836 euro in 2024. The Net Profit increased by 95.678 euro, from 251.889 euro in 2023, to 346.159 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Worldwide Clinical Trials Limited Londra Sucursala

Rating financiar

Financial Rating -
WORLDWIDE CLINICAL TRIALS LIMITED...

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Worldwide Clinical Trials Limited...

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Worldwide Clinical Trials Limited...

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Worldwide Clinical Trials Limited...

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Worldwide Clinical Trials Limited Londra Sucursala - CUI 25575730

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 2.555 2.723 1.892 5.030 3.401 2.032 887 170 6.684 10.908
Current Assets 374.943 994.084 1.347.164 1.511.015 1.751.248 2.110.540 1.386.154 1.250.360 1.189.582 1.707.998
Inventories 382 378 479 470 779 0 0 0 0 0
Receivables 342.708 976.172 1.344.592 1.507.260 1.747.700 2.110.057 1.386.154 1.248.011 1.189.582 1.707.946
Cash 31.852 17.534 2.093 3.286 2.769 483 0 2.348 0 52
Shareholders Funds 319.887 343.103 342.494 378.727 489.267 563.629 671.594 846.371 1.095.694 1.435.730
Social Capital 0 0 0 0 0 0 0 0 0 0
Debts 59.293 655.485 1.007.939 1.138.887 1.267.939 1.550.850 716.310 404.260 108.604 308.532
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "7490 - 7490"
CAEN Financial Year 7490
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 1.707.998 euro in 2024 which includes Inventories of 0 euro, Receivables of 1.707.946 euro and cash availability of 52 euro.
The company's Equity was valued at 1.435.730 euro, while total Liabilities amounted to 308.532 euro. Equity increased by 346.160 euro, from 1.095.694 euro in 2023, to 1.435.730 in 2024.

Risk Reports Prices

Reviews - Worldwide Clinical Trials Limited Londra Sucursala

Comments - Worldwide Clinical Trials Limited Londra Sucursala Bucuresti

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.